(+)-VINCRISTINE
B Lymphoblastic Lymphoma
Alliance for Clinical Trials in OncologySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
19 Active assets in the B Lymphoblastic Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Inotuzumab Ozogamicin Alliance for Clinical Trials in Oncology | Phase 3 | BB |
VINCRISTINE SULFATE Children's Oncology Group | Phase 3 | BB |
Blinatumomab Children's Oncology Group | Phase 3 | BB |
PREDNISONE TABLETS Alliance for Clinical Trials in Oncology | Phase 3 | BB |
MERCAPTOPURINE ANHYDROUS Alliance for Clinical Trials in Oncology | Phase 3 | BB |
View all 22 →
Same molecule, other indications
(+)-VINCRISTINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →